Dr. Lobl has over 55 years of experience in the pharmaceutical and medical device industries His experience includes immunology, inflammatory, infectious, cancer, reproductive and endocrinology disease areas. He has participated in an Ad Hoc UCLA longevity committee that evaluated publications on longevity, stem cells and senescence scientific work. The longevity committee studied super-centenarians (people over 110 years of age) and tried to identify markers associated with their longevity. Dr. Lobl has a PhD from Johns Hopkins Univ. and post-graduate work at Caltech and Rockefeller Univ and is a Fellow of the American Institute for Medical and Biological Engineering.